Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 3
2019 2
2020 2
2021 11
2022 10
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.
Tang K, Seo J, Tiu BC, Le TK, Pahalyants V, Raval NS, Ugwu-Dike PO, Zubiri L, Naranbhai V, Carrington M, Gusev A, Reynolds KL, LeBoeuf NR, Asgari MM, Kwatra SG, Semenov YR. Tang K, et al. Among authors: pahalyants v. JAMA Dermatol. 2022 Feb 1;158(2):189-193. doi: 10.1001/jamadermatol.2021.5476. JAMA Dermatol. 2022. PMID: 35019948 Free PMC article.
Characterization of the active Medicare dermatology workforce.
Murphy W, Pahalyants V, Gunasekera N, Shi CR, Nambudiri VE. Murphy W, et al. Among authors: pahalyants v. J Am Acad Dermatol. 2022 May;86(5):1140-1142. doi: 10.1016/j.jaad.2021.03.123. Epub 2021 Apr 18. J Am Acad Dermatol. 2022. PMID: 33878408 No abstract available.
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study.
Tiu BC, Zubiri L, Iheke J, Pahalyants V, Theodosakis N, Ugwu-Dike P, Seo J, Tang K, Sise ME, Sullivan R, Naidoo J, Mooradian MJ, Semenov YR, Reynolds KL. Tiu BC, et al. Among authors: pahalyants v. J Immunother Cancer. 2022 Jun;10(6):e004670. doi: 10.1136/jitc-2022-004670. J Immunother Cancer. 2022. PMID: 35705313 Free PMC article.
Latent class analysis identification of prurigo nodularis comorbidity phenotypes.
Wongvibulsin S, Parthasarathy V, Pahalyants V, Murphy W, Sutaria N, Roh YS, Bordeaux ZA, Deng J, Taylor MT, Semenov YR, Kwatra SG. Wongvibulsin S, et al. Among authors: pahalyants v. Br J Dermatol. 2022 May;186(5):903-905. doi: 10.1111/bjd.20957. Epub 2022 Mar 25. Br J Dermatol. 2022. PMID: 34927720 No abstract available.
Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Klebanov N, Pahalyants V, Murphy WS, Theodosakis N, Zubiri L, Klevens RM, Kwatra SG, Lilly E, Reynolds KL, Semenov YR. Klebanov N, et al. Among authors: pahalyants v. Oncologist. 2021 May;26(5):e898-e901. doi: 10.1002/onco.13768. Epub 2021 Apr 17. Oncologist. 2021. PMID: 33783099 Free PMC article.
28 results